APA (7th ed.) Citation

Dhar, S. S., Brown, C., Rizvi, A., Reed, L., Kotla, S., Zod, C., . . . Lee, M. G. (2025). Heterozygous Kmt2d loss diminishes enhancers to render medulloblastoma cells vulnerable to combinatory inhibition of LSD1 and OXPHOS. Cell Reports, 44(5), . https://doi.org/10.1016/j.celrep.2025.115619

Chicago Style (17th ed.) Citation

Dhar, Shilpa S., et al. "Heterozygous Kmt2d Loss Diminishes Enhancers to Render Medulloblastoma Cells Vulnerable to Combinatory Inhibition of LSD1 and OXPHOS." Cell Reports 44, no. 5 (2025). https://doi.org/10.1016/j.celrep.2025.115619.

MLA (9th ed.) Citation

Dhar, Shilpa S., et al. "Heterozygous Kmt2d Loss Diminishes Enhancers to Render Medulloblastoma Cells Vulnerable to Combinatory Inhibition of LSD1 and OXPHOS." Cell Reports, vol. 44, no. 5, 2025, https://doi.org/10.1016/j.celrep.2025.115619.